4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-17-021279
Chief Business Officer sold 27,154 shares at an average $20.08 ($545,162)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Business Officer | 2017-08-28 | Sale | −23,154 | $20.09 | $465,162 | 110,893 | D: show line 1 in the form |
| Kulkarni Samarth Chief Business Officer | 2017-08-30 | Sale | −4,000 | $20.00 | $80,000 | 106,893 | D: show line 2 in the form |
| Open-market sales · 27,154 sh · avg $20.08 · $545,162 | |||||||
Loading xslF345X03/doc4.xml…